Your browser doesn't support javascript.
loading
Interobserver Agreement in the Diagnosis of Parkinson Disease with Cardiac 123I-Metaiodobenzylguanidine Scintigraphy.
Foley, Robert W; Redman, Stewart L; Laurence, Isabel J; Graham, Richard N; Little, David.
Afiliación
  • Foley RW; Department of Radiology, Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom; and rwjfoley@gmail.com.
  • Redman SL; Department of Radiology, Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom; and.
  • Laurence IJ; Department of Radiology, Southmead Hospital, North Bristol NHS Trust, North Bristol, United Kingdom.
  • Graham RN; Department of Radiology, Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom; and.
  • Little D; Department of Radiology, Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom; and.
J Nucl Med Technol ; 49(3): 262-264, 2021 Sep.
Article en En | MEDLINE | ID: mdl-33820859
The aim of this study was to analyze the interobserver agreement of visual and quantitative assessment of cardiac 123I-metaiodobenzylguanidine scintigraphy. Methods: Planar images were acquired using a low-energy collimator. The heart-to-mediastinum (HM) ratio was adjusted for the use of a low-energy collimator, using a published formula. Interpretation was undertaken both visually and after the addition of adjusted HM ratios. Image findings were classified as normal, abnormal, or borderline. Results: The cohort consisted of 10 patients. On visual interpretation only, there was strong agreement on the interpretation of the scan (κ = 0.82, P < 0.01). Adjusted HM ratios led to a significant increase in mean ratios (1.79 vs. 1.36, P = 0.02) and, when utilized in reporting, resulted in perfect agreement (κ = 1.0, P < 0.01). Conclusion: The use of quantified HM ratios adjusted for low-energy collimator use improves on visual assessment alone and allowed for excellent interobserver agreement.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / 3-Yodobencilguanidina Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Nucl Med Technol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / 3-Yodobencilguanidina Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Nucl Med Technol Año: 2021 Tipo del documento: Article